A structured checklist for distributors and brand owners sourcing Lauha Bhasma-based Ayurvedic tablets in bulk, covering bhasma quality.
Lauha Bhasma-based tablets are regularly procured by distributors, hospital pharmacies and branded Ayurvedic companies in significant volumes. Sourcing them at scale from a GMP-certified manufacturer requires a structured checklist covering bhasma quality, raw material traceability, analytical testing and regulatory documentation before any purchase order is raised.
Lauha Bhasma is the principal active constituent in formulations such as Mandoor Vataka, Navayas Lauh, Saptamrit Lauha and Punarnava Mandoor. The quality of the finished tablet depends directly on the quality of the bhasma used in its production. A bhasma that has not completed the correct number of shodhana (purification) and marana (incineration) cycles will not meet the pharmacopoeial specifications for colour, fineness, iron content or heavy metal limits.
Under Schedule T of the Drugs and Cosmetics Act, a GMP-certified manufacturer is required to maintain complete batch records for every ingredient, including the Lauha Bhasma used in each production run. If a supplier cannot produce those batch records on request, that is a compliance gap that should disqualify them from your approved supplier list.
The Ayurvedic Pharmacopoeia of India sets the benchmark. Any manufacturer supplying Lauha Bhasma-based tablets under an AYUSH licence is expected to meet those specifications. Asking to see the pharmacopoeial reference and confirming that the manufacturer's in-house test methods align with it is a reasonable first step in any sourcing evaluation.
Before committing to a bulk order, a buyer should request and review the following documents from any prospective supplier in the Lauha-Mandoor category.
Product specification sheet: this document lists the formulation name, the AFI (Ayurvedic Formulary of India) reference number or Ayurvedic Pharmacopoeia of India reference, the complete ingredient list with quantities per unit, the dosage form, shelf life and storage conditions. Confirm that the ingredient list matches the AFI or pharmacopoeia specification for the formulation you are buying. Deviations from the classical composition must be disclosed.
Manufacturing process overview: a reputable GMP manufacturer will be able to explain, at a general level, the number of shodhana cycles applied to the raw iron, the incineration cycle count for the bhasma, and the quality release criteria for the finished bhasma before it enters tablet production. You do not need proprietary detail, but you need enough to assess whether the process is competent.
AYUSH manufacturing licence: confirm that the licence is current and that the Lauha-Mandoor category is listed within its scope. This is a public document and can be cross-referenced with the state licensing authority.
GMP certificate: a valid GMP certificate issued under Schedule T is a minimum requirement. Confirm the certificate number, the certifying authority and the expiry date.
The following tests should appear on the certificate of analysis for any batch of Lauha Bhasma-based tablets you accept into your supply chain.
Identity and description: visual description, colour, shape and any coating should match the approved specification. A significant departure from expected colour in the finished tablet can indicate a bhasma quality issue upstream.
Total iron content: measured by atomic absorption spectroscopy (AAS) or inductively coupled plasma optical emission spectroscopy (ICP-OES), this confirms that the Lauha Bhasma was present in the correct quantity and that the incineration was complete. The Ayurvedic Pharmacopoeia of India gives limits for total iron in finished bhasma preparations.
Heavy metal screening: lead, arsenic, mercury and cadmium must each be within the pharmacopoeial limits. This is a non-negotiable test for any mineral-containing Ayurvedic tablet. Classical Ayurvedic manufacturing involves metal incineration, and heavy metal screening is the modern verification that the process was controlled correctly.
Microbial limits: total aerobic microbial count, total combined yeast and mould count, and absence of specified pathogens including Salmonella and E. coli are standard requirements for oral dosage forms under Schedule T.
Loss on drying: this measures residual moisture content. Tablets with excess moisture are prone to degradation in transit or storage, particularly in the humid conditions of an Indian monsoon season.
Disintegration time: for tablet formulations, a disintegration test confirms the physical integrity of the dosage unit.
Raw material traceability is a core GMP requirement, not a value-added service. A competent manufacturer maintains an inward goods register that logs each ingredient by supplier, lot number, date of receipt, quantity and incoming quality control result.
For the iron raw material used to produce Lauha Bhasma, the inward record should identify the source and grade of iron used and the incoming test result confirming its suitability for bhasma production. For herbal ingredients such as Triphala components, Vidanga or Trikatu (depending on the formulation), the inward record should include the botanical identity test result confirming the correct species was supplied.
Adulteration of herbal raw materials is a known issue in Ayurvedic manufacturing. A supplier who performs thin-layer chromatography or HPLC-based identity testing on key herbals provides a higher level of assurance than one relying solely on visual identification.
When you conduct a supplier audit or request a documentation review, ask specifically to see three or four recent inward records for the most critical ingredients in the formulation you are buying. If those records do not exist or are incomplete, treat it as a material deficiency.
Every bulk consignment of Lauha Bhasma-based tablets from a GMP-certified manufacturer should be accompanied by a certificate of analysis specific to the batch being supplied. A generic product-level quality report that is not batch-specific does not satisfy Schedule T requirements and should not be accepted.
The certificate of analysis should include the product name, batch number, manufacturing date, expiry date, and the results for each test parameter listed in the product specification. It should carry the signature of the responsible quality control officer.
For interstate movement within India, the consignment should be accompanied by a valid invoice, a transport document and, where applicable, a Form 26 or equivalent state-specific movement permit as required under the Drugs and Cosmetics Act.
For bulk supply to exporters, the documentation requirements expand to include country-of-origin certificates, free-sale certificates and, where required by the importing country, analysis reports from a government-accredited laboratory.
Raasa Ayurveda supplies 17 classical Lauha-Mandoor formulations from its GMP-certified (D-5755/09) and AYUSH-licensed (A-4177/2009) facility in Kanpur, Uttar Pradesh, with a certificate of analysis accompanying every consignment. Samples are available before bulk commitment. To discuss your requirements or request documentation for your due-diligence review, write to raasaayurveda@gmail.com or telephone +91 9415128217.
A certificate of analysis for each batch should include total iron content by AAS or ICP-OES, heavy metal limits for lead, arsenic, mercury and cadmium, microbial limits, loss on drying and disintegration time. The report should be batch-specific, not a generic product-level document, and should be signed by the manufacturer's quality control officer.
Ask for the GMP certificate number issued under Schedule T of the Drugs and Cosmetics Act and cross-check it with the relevant state licensing authority. Also confirm that the AYUSH manufacturing licence covers the Lauha-Mandoor category. Both are public documents and a legitimate manufacturer will provide them without hesitation.
Minimum order quantities depend on the specific formulation, the manufacturing batch size the supplier typically runs, and your packaging requirements. The right way to determine this is through a direct discussion with the manufacturer. Ask for a quotation that specifies batch size, and request a sample order first to confirm quality before committing to bulk volumes.
A GMP-certified manufacturer with confidence in their product should offer samples ahead of a bulk commitment. Use the sample to conduct an independent laboratory test covering iron content and heavy metals before finalising the supply contract. This is standard practice in Ayurvedic B2B procurement and a reputable supplier will expect and support it.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.